BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20685876)

  • 1. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance.
    Ayala JE; Bracy DP; James FD; Burmeister MA; Wasserman DH; Drucker DJ
    Endocrinology; 2010 Oct; 151(10):4678-87. PubMed ID: 20685876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.
    Ayala JE; Bracy DP; James FD; Julien BM; Wasserman DH; Drucker DJ
    Endocrinology; 2009 Mar; 150(3):1155-64. PubMed ID: 19008308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin action in the double incretin receptor knockout mouse.
    Ayala JE; Bracy DP; Hansotia T; Flock G; Seino Y; Wasserman DH; Drucker DJ
    Diabetes; 2008 Feb; 57(2):288-97. PubMed ID: 17977951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor.
    Burmeister MA; Bracy DP; James FD; Holt RM; Ayala J; King EM; Wasserman DH; Drucker DJ; Ayala JE
    J Physiol; 2012 Oct; 590(20):5245-55. PubMed ID: 22890715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
    Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
    Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMP-angiopoietin-1 enhances skeletal muscle blood flow and insulin sensitivity in mice.
    Sung HK; Kim YW; Choi SJ; Kim JY; Jeune KH; Won KC; Kim JK; Koh GY; Park SY
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E402-9. PubMed ID: 19491299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.
    Park SY; Kim HJ; Wang S; Higashimori T; Dong J; Kim YJ; Cline G; Li H; Prentki M; Shulman GI; Mitchell GA; Kim JK
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E30-9. PubMed ID: 15701680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.
    Pocai A; Carrington PE; Adams JR; Wright M; Eiermann G; Zhu L; Du X; Petrov A; Lassman ME; Jiang G; Liu F; Miller C; Tota LM; Zhou G; Zhang X; Sountis MM; Santoprete A; Capito' E; Chicchi GG; Thornberry N; Bianchi E; Pessi A; Marsh DJ; SinhaRoy R
    Diabetes; 2009 Oct; 58(10):2258-66. PubMed ID: 19602537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice.
    Kang L; Mayes WH; James FD; Bracy DP; Wasserman DH
    Diabetologia; 2014 Mar; 57(3):603-13. PubMed ID: 24305966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents.
    Kim T; Holleman CL; Nason S; Arble DM; Ottaway N; Chabenne J; Loyd C; Kim JA; Sandoval D; Drucker DJ; DiMarchi R; Perez-Tilve D; Habegger KM
    Diabetes; 2018 Nov; 67(11):2157-2166. PubMed ID: 30150304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 contributes to hyaluronan-mediated insulin resistance in skeletal muscle of high-fat-fed C57BL/6 mice.
    Hasib A; Hennayake CK; Bracy DP; Bugler-Lamb AR; Lantier L; Khan F; Ashford MLJ; McCrimmon RJ; Wasserman DH; Kang L
    Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E973-E983. PubMed ID: 31550181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac1 muscle knockout exacerbates the detrimental effect of high-fat diet on insulin-stimulated muscle glucose uptake independently of Akt.
    Raun SH; Ali M; Kjøbsted R; Møller LLV; Federspiel MA; Richter EA; Jensen TE; Sylow L
    J Physiol; 2018 Jun; 596(12):2283-2299. PubMed ID: 29749029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.
    Parlevliet ET; Schröder-van der Elst JP; Corssmit EP; Picha K; O'Neil K; Stojanovic-Susulic V; Ort T; Havekes LM; Romijn JA; Pijl H
    J Pharmacol Exp Ther; 2009 Jan; 328(1):240-8. PubMed ID: 18849357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.
    Ali S; Lamont BJ; Charron MJ; Drucker DJ
    J Clin Invest; 2011 May; 121(5):1917-29. PubMed ID: 21540554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.
    Ye JM; Tid-Ang J; Turner N; Zeng XY; Li HY; Cooney GJ; Wulff EM; Sauerberg P; Kraegen EW
    Br J Pharmacol; 2011 Jun; 163(3):556-66. PubMed ID: 21265823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.
    Sisley S; Gutierrez-Aguilar R; Scott M; D'Alessio DA; Sandoval DA; Seeley RJ
    J Clin Invest; 2014 Jun; 124(6):2456-63. PubMed ID: 24762441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.
    Guo T; Jou W; Chanturiya T; Portas J; Gavrilova O; McPherron AC
    PLoS One; 2009; 4(3):e4937. PubMed ID: 19295913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.